Health IT Analytics September 26, 2018
Consumers are interested in how artificial intelligence and genetic testing can change the process of seeking care for cancer, but they are equally concerned about the costs.
Healthcare consumers are cautious but optimistic that emerging strategies like artificial intelligence and advanced genetic testing can lead to better care for cancer, according to a new survey from McKesson and Ipsos.
The poll of more than 2000 individuals found that close to two-thirds (60 percent) of respondents are open to the idea of using genetic testing to identify their risk of developing cancer.
“It’s exciting to see that as genomic medicine is becoming more accessible and affordable, people are willing to embrace DNA testing to learn their potential genetic predispositions,” said Michael...
Today's Sponsors
Today's Sponsor